Summit Therapeutics
SMMT
SMMT
237 hedge funds and large institutions have $2.08B invested in Summit Therapeutics in 2025 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 66 increasing their positions, 74 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
237
Holders Change
+26
Holders Change %
+12.32%
% of All Funds
3.18%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.05%
New
73
Increased
66
Reduced
74
Closed
45
Calls
$126M
Puts
$77.1M
Net Calls
+$49.1M
Net Calls Change
+$69.3M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$198M |
| 2 |
ACL
APEIRON Capital Ltd
Hong Kong
|
+$23.2M |
| 3 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$21.3M |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$17.7M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$16.7M |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$63.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$56.4M |
| 3 |
BlackRock
New York
|
-$33M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$32.9M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$22.7M |
